Success Story: Rapid EB-1A Approval in 20 Days for a Health Policy Specialist Focused on Rural Cancer Care Disparities

 

Client’s Testimonial:

“Easy conversion from NIW to EB-1A, thanks to the team.”


On January 15th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for an Associate Scientist in the Field of Health Policy (Approval Notice).


General Field: Health Policy

Position at the Time of Case Filing: Research Scientist

Country of Origin: China

State of Residence at the Time of Filing: North Carolina

Approval Notice Date: January 15th, 2026

Processing Time: 20 days (Premium Processing Requested)


Case Summary:  

Improving health outcomes often depends on whether evidence can reveal where access breaks down and which policies actually change care delivery. In this EB-1A case, the client built a specialized record in health policy at the intersection of health services research, epidemiology, and biostatistics, with a particular focus on addressing racial and geographic disparities in rural cancer care access. We presented the case around that practical impact, showing how the client’s research moves beyond descriptive statistics into actionable insights that can inform policy design and evidence-based decision-making.

With an M.P.H. in Epidemiology, the client has developed a data-driven research profile centered on evaluating healthcare access and outcomes for underserved populations. The petition also documented that the client is currently employed in a U.S.-based research role supporting large-scale quantitative analyses of cancer and health disparities data, reinforcing that the client is actively positioned to continue producing high-value work in the area of extraordinary ability.

The client’s influence was reflected in objective evidence of independent reliance. The client authored 31 peer-reviewed journal articles, 24 abstracts, 1 preprint, 1 book chapter, and 2 technical reports, and the published body of work has been cited 631 times. We did not present these totals as self-proving. Instead, we explained how an adjudicator could reasonably interpret the record as showing that independent researchers repeatedly use the client’s findings to support and validate subsequent work on healthcare access, disparities, and outcomes. We also highlighted that more than two dozen of the client’s papers ranked among the most highly cited in their category for their publication years, and that independent bibliometric indicators placed the client within a top-percentile cohort for influence in relevant topic areas. This helped translate citations into the adjudicator-facing takeaway that the client’s work is not only published but consistently relied upon.

Peer recognition extended beyond publications. The client has completed at least 32 peer reviews, which we framed as sustained peer trust in the client’s expertise and judgment to evaluate other researchers’ work. We also included evidence of research support from the National Institutes of Health, presenting it as objective reinforcement that the client’s research direction aligns with competitively supported priorities tied to improving health equity and healthcare delivery.

With the evidence organized around originality, independent reliance, and sustained peer trust, the EB-1A petition was approved in just 20 days under Premium Processing.